CANCER BUZZ PODCAST

Hear how malnutrition affects people with cancer in different ways, even impacting cancer treatment plans.

Allowing APPs to sign anti-cancer treatment orders not only improves access to high-quality cancer care, it can also free up physician time to see more new patients and streamline clinic workflow.

People were avoiding hospitals during COVID-19, which could have impacted cancer detection rates. The James Cancer Hospital opened a new facility where patients can receive several services in one place.

Baptist Health South Florida, Miami Cancer Institute in Florida turned to technology to provide high-quality cancer care without having to dip deeper into its operating budget.

Since implementation, Chemotherapy Care Companion has decreased patients’ healthcare costs by preventing emergency department (ED) visits and hospitalizations and improved their overall satisfaction.

Hear how malnutrition affects people with cancer in different ways, even impacting cancer treatment plans.

Hear about a treatment plan collaboration between the oncology care team and PCP from one of our 2022 ACCC Innovator Award winners—ChristianaCare's Helen F. Graham Cancer Center & Research Institute.

With the emergence of oral cancer therapies, it is a very exciting time in cancer care. But these treatments can come with adverse events.

While patients with cancer face many physical and psychological challenges associated with their disease and/or treatment, their social, emotional, and legal needs can lead to ongoing health disparities and reduced quality of life if left unaddressed.

To help older patients become digitally literate, the "Patient Empowerment Network" offers a free program that teaches older adults with cancer valuable technology skills.

The demand for medical cannabis education from both providers and patients is increasing dramatically as stigma on its use decreases. Learn how one cancer clinic is helping meet this growing need.

Allen Beck & Rivka Shakow Beck were newlyweds when Allen was diagnosed with MDS. Allen & Rivka were thrust into a stressful situation, but financial advocate, Angie Santiago, CRCS, was ready to help.

Listen to ACCC's Matt Devino & President of the Empire State Hematology & Oncology Society, Rahul Seth, DO, discuss why every voice is critical in grassroot advocacy efforts.

Patients with blood cancers require better access to clinical trials. The Leukemia and Lymphoma Society's developed a tool that connects patients with clinical trials that best fit their unique needs.

Hear how this cancer center created a model for integrating advanced practitioners into a radiation oncology satellite clinic to provide long-term follow-up care and survivorship services.

Stephen Quake, PhD, spoke to CANCER BUZZ about the application of liquid biopsies across multiple cancer stages and their potential to improve patient outcomes.

Hear how measurable residual disease (MRD) testing has the potential to become more fully integrated into clinical practice as one of the reliable markers of treatment response for patients with multiple myeloma and chronic lymphocytic leukemia.

Hear how measurable residual disease (MRD) testing has the potential to become more fully integrated into clinical practice as one of the reliable markers of treatment response for patients with multiple myeloma and chronic lymphocytic leukemia.

Learn how state oncology societies have the power to mobilize larger groups of providers across the state to make their voices heard on behalf of their patients—and how you can get involved.  

CANCER BUZZ spoke to Mike McGarry, who—following his wife’s cancer diagnosis—was introduced to Jack’s Caregiver Coalition, a non-profit dedicated to supporting men throughout the caregiver journey.

Hear how a virtual integrative format can enable cancer programs to adapt touch modalities to self-interventions, leverage opportunities for research, and overcome social and economic barriers.

Live from the ACCC 48th Annual Meeting & Cancer Center Business Summit, a veteran of value-based payment models identifies her top three takeaways on the future of precision medicine reimbursement.

Hear from the co-founder of the Imagination Lab for Clinical Innovation at LIVESTRONG Cancer Institutes on effective practices for measuring new models of care.

Dr. Jennie R. Crews, ACCC 2016-17 President, discusses ACCC's involvement in the White House's Cancer Moonshot initiative--from its launch in 2016 to the new energy generated by President Biden's revamp of the program in February 2022.

Harlan Levine, MD, spoke to CANCER BUZZ during the ACCC 48th Annual Meeting & Cancer Center Business Summit to share his top takeaways from the stage.

Hear from a pharmacist and an oncology operations manager as they share how this tool can help you find resources in less time so patients can access—and better afford—their cancer treatments.

Simplifying and standardizing pathology reports so patients are better informed, understand their prognosis, and own the progress of their therapies is of critical importance in today's episode.

In this episode, hear from two experts in cancer immunotherapy on the exciting potential of TIL Cell Therapy in melanoma and beyond.

Krista Nelson, ACCC 2021-2022 President, discusses two new resources (business case brief for hiring and benchmarking survey) that demonstrate the value oncology social workers play in cancer care.

Biomarker testing is crucial to precision medicine, but barriers still exist. Learn from two healthcare advocates about recent policy changes designed to ensure better access to biomarker testing.